Prognostic Value of Scores Based on Malnutrition or Systemic Inflammatory Response in Patients With Metastatic or Recurrent Gastric Cancer

REFERENCES

• Ovesen L, Allingstrup L, Hannibal J, Mortensen EL, and Hansen OP: Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy. A prospective randomized study. J Clin Oncol 11, 2043–2049, 1993.
   PubMed Web of Science ®Google Scholar
• Davidson W, Ash S, Capra S, Bauer J, Cancer Cachexia Study Group: Weight stabilization is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23, 239–247, 2004.
   PubMed Web of Science ®Google Scholar
• O’Gorman P, McMillan DC, and McArdle CS: Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32, 76–80, 1998.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Voss AC, Hustead DS, and Cancer Cachexia Study Group: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. AmJ Clin Nutr 83, 1345–1350, 2006.
   PubMed Web of Science ®Google Scholar
• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients: Eastern Cooperative Oncology Group. Am J Med 69, 69, 491–497, 1980.
   PubMed Web of Science ®Google Scholar
• Maltoni M and Amadori D: Prognosis in advanced cancer. Hematol Oncol Clin North Am 16, 715–729, 2002.
   PubMed Web of Science ®Google Scholar
• Seve P, Ray-Coquard I, Trillet-Lenoir V, Sawyer M, Hanson J, et al.: Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 107, 2698–2705, 2006.
   PubMed Web of Science ®Google Scholar
• Lam PT, Leung MW, and Tse CY: Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J 13, 453–459, 2007.
   PubMedGoogle Scholar
• Siddiqui A, Heinzerling J, Livingston EH, and Huerta S: Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 194, 362–366, 2007.
   PubMed Web of Science ®Google Scholar
• Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, et al.: Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol 14, 381–389, 2007.
   PubMed Web of Science ®Google Scholar
• Heys SD, Walker LG, Deehan DJ, and Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J Coll Surg Edinb 43, 163–168, 1998.
   Web of Science ®Google Scholar
• Lis CG, Grutsch JF, Vashi PG, and Lammersfeld CA: Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN 27, 10–15, 2003.
   PubMed Web of Science ®Google Scholar
• Gupta D and Lis CG: Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9, 69–74, 2010.
   PubMed Web of Science ®Google Scholar
• Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, et al.: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non small cell lung cancer. Br J Cancer 87, 264–267, 2002.
   PubMed Web of Science ®Google Scholar
• Wigmore SJ, Plester CE, Ross JA, and Fearon KC: Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84, 196–197, 1997.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, et al.: A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170, 319–322, 1995.
   PubMed Web of Science ®Google Scholar
• Wang CY, Hsieh MJ, Chiu YC, Li SH, Huang HW, et al.: Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol 92, 270–275, 2009.
   PubMed Web of Science ®Google Scholar
• Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, et al.: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75, 2077–2082, 1995.
   PubMed Web of Science ®Google Scholar
• Hilmy M, Campbell R, Bartlett JM, McNicol AM, Underwood MA, et al.: The relationship between the systemic inflammatory response, tumour proliferative activity, T lymphocytic infiltration and COX 2 expression and survival in patients with transitional cell carcinoma of urinary bladder. Br J Cancer 95, 1234–1238, 2006.
   PubMed Web of Science ®Google Scholar
• Bozzetti F: Nutritional support of oncology patient. Critical Reviews in Oncology/Hematology 87, 172–200, 2013.
   PubMed Web of Science ®Google Scholar
• Migita K, Takayama T, Saeki K, Matsumoto, Wakatsuki K, et al.: The Prognostic Nutritional Index predicts long term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20, 2647–2654, 2013.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, et al.: Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today 40, 440–443, 2010.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iwatsuki M, Iwagami S, Ishimoto T, and Baba Y: Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg 36, 1632–1639, 2012.
   PubMed Web of Science ®Google Scholar
• Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, et al.: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer 11, 489, 2011.
   PubMed Web of Science ®Google Scholar
• Ryu SW and Kim IH: Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients. World J Gastroenterol 16, 3310–3317, 2010.
   PubMed Web of Science ®Google Scholar
• Harell FE Jr, Lee KL, and Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15, 361–387, 1996.
   PubMed Web of Science ®Google Scholar
• van Halteren HK and Jatoi A: Cancer and the nutritional status. In: Nutrition and Cancer, van Halteren H, and Jatoi A (eds.). Viganello-Lugano, ESMO Head Office, 2011, pp. 28–32.
   Google Scholar
• Maurício SF, da Silva JB, Bering T, and Correia MI: Relationship between nutritional status and the Glasgow prognostic score in patients with colorectal cancer. Nutrition 29, 625–629, 2013.
   PubMed Web of Science ®Google Scholar
• Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clinical Nutrition 32: 65–72, 2013.
   PubMed Web of Science ®Google Scholar
• Ripamonti CI, Farina G, and Garassino MC: Predictive models in palliative care. Cancer 115(13, Suppl), 3128–3134, 2009.
   PubMed Web of Science ®Google Scholar
• Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, et al.: Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non small cell lung cancer. Br J Cancer 85, 1634–1639, 2001.
   PubMed Web of Science ®Google Scholar
• Al-Shaiba R, McMillan DC, Angerson WJ, Leen E, McArdle CS, et al.: The relationship between hypoalbuminaemia, tumor volume and the systemic inflammatory response in patiens with colorectal liver metastases. Br J Cancer 91, 205–207, 2004.
   PubMed Web of Science ®Google Scholar
• Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, et al.: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138, 962–966, 2003.
   PubMed Web of Science ®Google Scholar
• Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, et al.: Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 8, 1041–1048, 2004.
   PubMed Web of Science ®Google Scholar
• Crumley AB, McMillan DC, McKernan M, McDonald AC, and Stuart RC: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94, 637–641, 2006.
   PubMed Web of Science ®Google Scholar
• Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, et al.: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer 9, 288, 2009.
   PubMed Web of Science ®Google Scholar
• Lis CG, Grutsch JF, Vashi PG, and Lammersfeld CA: Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN 27, 10–15, 2003.
   PubMed Web of Science ®Google Scholar
• Zadak Z: Vyziva v intenzivni peci (2nd ed.). Prague, Czech Republic: Grada Publishing, 2008.
   Google Scholar
• Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, et al.: Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62, 265–279, 2011.
   PubMed Web of Science ®Google Scholar
• Laviano A, Meguid MM, Preziosa I, and Fanelli FR: Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 10, 449–456, 2007.
   PubMed Web of Science ®Google Scholar
• Deans DAC, Tan KCH, Wigmore SJ, Ross JA, Beaux AC, et al:The influence of systemic inflamation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100, 63–69, 2009.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34: 503–509, 1998.
   PubMed Web of Science ®Google Scholar
• Abernethy AP and Wheeler JL: Total parenteral nutrition for patients with advanced, life-limiting cancer. In: Diet and Nutrition in Palliative Care, Preedy VR (ed.). Boca Raton, FL, Taylor & Francis, 2011, pp. 289–301.
   Google Scholar
• Martinez-Outschoorn UE, Lisanti MP, and Sotgia F. Catabolic cancer-associated fibroblasts (CAFs) transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol 2014. [Epub ahead of print.] doi:10.1016/j.semcancer.2014.01.005
   PubMed Web of Science ®Google Scholar
• Punzi T, Fabris A, Morucci G, Biagioni P, Gulisano M, et al.: C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients. Mol Diagn Ther 16, 115–124, 2012.
   PubMed Web of Science ®Google Scholar